Hohimer Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.78M Buy
+47,206
New +$3.89M 0.45% 68
2024
Q2
Sell
-7,246
Closed -$692K 230
2024
Q1
$692K Buy
7,246
+171
+2% +$14.4K 0.16% 140
2023
Q4
$539K Sell
7,075
-365
-5% -$25.4K 0.14% 149
2023
Q3
$515K Buy
7,440
+136
+2% +$10.9K 0.15% 144
2023
Q2
$689K Sell
7,304
-174
-2% -$15.1K 0.19% 129
2023
Q1
$619K Buy
7,478
+1,852
+33% +$146K 0.18% 137
2022
Q4
$420K Sell
5,626
-1,674
-23% -$129K 0.13% 124
2022
Q3
$603K Sell
7,300
-7
-0.1% -$674 0.19% 130
2022
Q2
$695K Sell
7,307
-3,510
-32% -$363K 0.21% 129
2022
Q1
$1.27M Sell
10,817
-129
-1% -$14.5K 0.25% 112
2021
Q4
$1.42M Buy
10,946
+19
+0.2% +$2.22K 0.3% 103
2021
Q3
$1.24M Buy
10,927
+117
+1% +$13.4K 0.26% 110
2021
Q2
$1.12M Buy
10,810
+926
+9% +$87.3K 0.23% 117
2021
Q1
$827K Sell
9,884
-6,451
-39% -$545K 0.2% 121
2020
Q4
$1.49M Buy
16,335
+72
+0.4% +$5.97K 0.39% 85
2020
Q3
$1.37M Buy
16,263
+299
+2% +$23.3K 0.39% 87
2020
Q2
$1.1M Buy
15,964
+1,072
+7% +$76.2K 0.38% 96
2020
Q1
$1.09M Sell
14,892
-5,406
-27% -$390K 0.46% 92
2019
Q4
$1.58M Buy
+20,298
New +$1.58M 0.55% 81

Other funds holding EW

Hohimer Wealth Management's EW Position: Q1 2026 in Review

Hohimer Wealth Management opened a new position in Edwards Lifesciences (EW) in Q1 2026: 47,206 shares worth $3.78M. The stake represents 0.45% of the portfolio and ranks #68 among its holdings. This is a return to the name: Hohimer Wealth Management previously reported a position in EW as recently as Q1 2024.

Hohimer Wealth Management first reported a position in EW in Q4 2019 and has held it in 19 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Hohimer Wealth Management held 47,206 shares of Edwards Lifesciences worth $3.78M as of Q1 2026.
  • Edwards Lifesciences was a new Hohimer Wealth Management position in Q1 2026.
  • Edwards Lifesciences made up 0.45% of Hohimer Wealth Management's portfolio in Q1 2026, its #68 holding.
  • Hohimer Wealth Management first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 19 quarters since.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Hohimer Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.